Next report date
Report period
Q1 2024
EPS estimate
−0.45CNY
Revenue estimate
—
−801.32 MCNY
1.21 MCNY
82.77 M
Om CHONGQING GENRIX BIOPHARMACEUTICAL
Sektor
Bransch
VD
Zhi Yuan Chang
Webbplats
Huvudkvarter
Chongqing
Grundat
2015
FIGI
BBG018CDC7M6
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
